Heart and lung transplantation in patients with end stage lung disease.

AUTOR(ES)

Penketh, A

RESUMO

Combined heart and lung transplantation was used to treat seven patients with end stage lung disease. All were severely disabled, and their disease carried a poor prognosis. Six patients were well four to 33 months after transplantation. One patient died after 44 days from a primary cytomegalovirus pneumonia transmitted from the donor. All the survivors had normal exercise tolerance and greatly improved lung function. It is concluded that heart and lung transplantation is a suitable treatment for selected patients with end stage chronic lung disease.

Documentos Relacionados

• Effect of single lung transplantation on pulmonary hypertension in patients with end stage fibrosing lung disease.
• Bilateral sequential lung transplantation for end stage septic lung disease.
• Pericardial effusions in patients with end-stage renal disease.
• Evaluation of bone disease in patients with cystic fibrosis and end-stage lung disease
• Cardiac transplantation for pediatric patients. With inoperable congenital heart disease.